Lenvatinib Inhibits Cholangiocarcinoma Progression by Targeting the FGF19/PI3K/AKT Signaling Pathway
Apoptosis an international journal on programmed cell death(2024)
Key words
Cholangiocarcinoma,Lenvatinib,Targeted therapy,FGF19,PI3K/AKT signaling pathway
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined